Search Results - "Dahlen, Jeffrey R."

Refine Results
  1. 1

    Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease by Kaikita, Koichi, Hosokawa, Kazuya, Dahlen, Jeffrey R, Tsujita, Kenichi

    Published in Thrombosis and haemostasis (01-10-2019)
    “…Various antithrombotic agents are clinically used to inhibit the cascade of arterial or venous thrombosis in cardiovascular diseases. Dual antiplatelet therapy…”
    Get more information
    Journal Article
  2. 2

    Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners by Peabody, John, Paculdo, David, Acelajado, M. Czarina, Burgon, Trever, Dahlen, Jeffrey R.

    “…HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated…”
    Get full text
    Journal Article
  3. 3

    Early Biomarkers of Stroke by Reynolds, Mark A, Kirchick, Howard J, Dahlen, Jeffrey R, Anderberg, Joseph M, McPherson, Paul H, Nakamura, Kevin K, Laskowitz, Daniel T, Valkirs, Gunars E, Buechler, Kenneth F

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2003)
    “…The diagnosis and management of acute ischemic stroke are limited by the lack of rapid diagnostic assays for use in an emergency setting. Computed tomography…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Differential inhibition of platelet function by cilostazol in combination with clopidogrel by Yamazaki, Masako, Shirai, Yuka, Ohnishi, Tomoko, Hosokawa, Kazuya, Dahlen, Jeffrey R., Kitagawa, Kazuo

    Published in European journal of clinical pharmacology (01-12-2023)
    “…Purpose To assess the antiplatelet effect of cilostazol clinically, we compared the effects of cilostazol in combination with clopidogrel on various platelet…”
    Get full text
    Journal Article
  6. 6

    First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19 by Tantry, Udaya S, Bliden, Kevin P, Cho, Alastair, Walia, Naval, Dahlen, Jeffrey R, Ens, Gordon, Traianova, Malina, Jerjian, Christophe, Usman, Abira, Gurbel, Paul A

    Published in Open forum infectious diseases (01-07-2021)
    “…Abstract Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2’-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the…”
    Get full text
    Journal Article
  7. 7

    1227-P: GlycoMark 1,5-Anhydrocluitol Values in Patients Taking SGLT2 Inhibitors by FEREIDOUNI, SAM S., SHOWS, THOMAS P., LESSARD-CHAUDOIN, CHANTELLE, BRABENTZ, KIM, TENOPALA, ROBERTO E., DAHLEN, JEFFREY R.

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…The GlycoMark test measures 1,5-anhydroglucitol (1,5-AG), which is an indicator of hyperglycemic excursions over the prior 1-2 weeks in patients with diabetes…”
    Get full text
    Journal Article
  8. 8

    Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists by Valdenor, Czarlota, McCullough, Peter A., Paculdo, David, Acelajado, M. Czarina, Dahlen, Jeffrey R., Noiri, Eisei, Sugaya, Takeshi, Peabody, John

    Published in Current problems in cardiology (01-09-2021)
    “…Contrast-induced acute kidney injury (CI-AKI) occurs in up to 10% of cardiac catheterizations and coronary interventions, resulting in increased morbidity,…”
    Get full text
    Journal Article
  9. 9

    Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures by Peabody, John, Paculdo, David, Valdenor, Czarlota, McCullough, Peter A., Noiri, Eisei, Sugaya, Takeshi, Dahlen, Jeffrey R.

    Published in Cardiorenal medicine (2022)
    “…Introduction: Contrast-induced acute kidney injury (CI-AKI) is a major clinical complication of percutaneous cardiovascular procedures requiring iodinated…”
    Get full text
    Journal Article
  10. 10

    ANTARCTIC: platelet function testing to adjust therapy by Gurbel, Paul A, Price, Matthew J, Dahlen, Jeffrey R, Tantry, Udaya S

    Published in The Lancet (British edition) (25-03-2017)
    “…In the GENERATIONS2 and TRILOGY ACS3 trials, the bleeding rates were the same between the prasugrel 5 mg and clopidogrel 75 mg groups. [...]the ANTARCTIC…”
    Get full text
    Journal Article
  11. 11

    Variation in Diabetes Management: A National Assessment of Primary Care Providers by Peabody, John W., de Belen, Enrico, Dahlen, Jeffrey R., Acelajado, Maria Czarina, Tran, Mary T., Paculdo, David R.

    Published in Journal of diabetes science and technology (01-01-2020)
    “…Background: Glucose control is monitored primarily through ordering HbA1c levels, which is problematic in patients with glycemic variability. Herein, we report…”
    Get full text
    Journal Article
  12. 12

    Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonism by Jakubowski, Joseph A, Zhou, Chunmei, Egan, Blaine, Wells, Maggie, Kotob-Yahfoufi, Maya, Sugidachi, Atsuhiro, Dahlen, Jeffrey R

    Published in Platelets (Edinburgh) (2011)
    “…The VerifyNow® P2Y12 (VN-P2Y12) test reports thienopyridine-mediated platelet inhibition relative to a "BASE" channel, potentially eliminating the need for…”
    Get full text
    Journal Article
  13. 13

    Inhibition of Soluble Recombinant Furin by Human Proteinase Inhibitor 8 by Dahlen, Jeffrey R., Jean, François, Thomas, Gary, Foster, Donald C., Kisiel, Walter

    Published in The Journal of biological chemistry (23-01-1998)
    “…Furin is a ubiquitous prototypical mammalian kexin/subtilisin-like endoproteinase that is involved in the proteolytic processing of a variety of proteins in…”
    Get full text
    Journal Article
  14. 14

    Molecular Cloning, Expression, and Partial Characterization of Two Novel Members of the Ovalbumin Family of Serine Proteinase Inhibitors(∗) by Sprecher, Cindy A., Morgenstern, Kurt A., Mathewes, Shannon, Dahlen, Jeffrey R., Schrader, Sara K., Foster, Donald C., Kisiel, Walter

    Published in The Journal of biological chemistry (15-12-1995)
    “…A human placental λgt11 cDNA library was screened for sequences encoding proteins related to human proteinase inhibitor 6 (PI6), and two plaques were…”
    Get full text
    Journal Article
  15. 15

    Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9 by Dahlen, Jeffrey R, Foster, Donald C, Kisiel, Walter

    Published in Biochimica et biophysica acta (21-09-1999)
    “…Proteinase inhibitor PI9 (PI9) is an intracellular 42-kDa member of the ovalbumin family of serpins that is found primarily in placenta, lung and lymphocytes…”
    Get full text
    Journal Article
  16. 16

    Expression, Purification, and Inhibitory Properties of Human Proteinase Inhibitor 8 by Dahlen, Jeffrey R, Foster, Donald C, Kisiel, Walter

    Published in Biochemistry (Easton) (02-12-1997)
    “…In a previous report, the cDNA for human proteinase inhibitor 8 (PI8) was first identified, isolated, and subcloned into a mammalian expression vector and…”
    Get full text
    Journal Article
  17. 17

    Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measures by Dahlen, J R, Price, M J, Parise, H, Gurbel, P A

    Published in Thrombosis and haemostasis (01-05-2013)
    “…Various diagnostic and prognostic performance measures have been used to describe the clinical usefulness of platelet function testing in the evaluation and…”
    Get more information
    Journal Article
  18. 18

    Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y12 antagonism by Jakubowski, Joseph A., Zhou, Chunmei, Egan, Blaine, Wells, Maggie, Kotob-Yahfoufi, Maya, Sugidachi, Atsuhiro, Dahlen, Jeffrey R.

    Published in Platelets (Edinburgh) (01-12-2011)
    “…The VerifyNow® P2Y12 (VN-P2Y12) test reports thienopyridine-mediated platelet inhibition relative to a "BASE" channel, potentially eliminating the need for…”
    Get full text
    Journal Article
  19. 19
  20. 20